Ulland Investment Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$292K Hold
1,043
0.22% 67
2026
Q1
$278K Hold
1,043
0.24% 63
2025
Q4
$262K Hold
1,043
0.21% 59
2025
Q3
$299K Sell
1,043
-63
-6% -$16.9K 0.23% 54
2025
Q2
$290K Sell
1,106
-175
-14% -$42.6K 0.22% 52
2025
Q1
$298K Sell
1,281
-77
-6% -$18.7K 0.25% 46
2024
Q4
$311K Sell
1,358
-10
-0.7% -$2.29K 0.2% 44
2024
Q3
$306K Sell
1,368
-165
-11% -$36.3K 0.22% 45
2024
Q2
$312K Sell
1,533
-257
-14% -$52.3K 0.22% 47
2024
Q1
$391K Sell
1,790
-91
-5% -$20K 0.31% 43
2023
Q4
$428K Sell
1,881
-25
-1% -$5.25K 0.43% 36
2023
Q3
$383K Sell
1,906
-565
-23% -$119K 0.42% 36
2023
Q2
$512K Hold
2,471
0.53% 36
2023
Q1
$487K Sell
2,471
-1,684
-41% -$347K 0.57% 36
2022
Q4
$841K Sell
4,155
-757
-15% -$148K 1% 27
2022
Q3
$864K Buy
4,912
+46
+0.9% +$9.42K 0.94% 29
2022
Q2
$980K Sell
4,866
-1,903
-28% -$406K 1% 28
2022
Q1
$1.53M Buy
6,769
+320
+5% +$75.3K 1.15% 25
2021
Q4
$1.74M Buy
+6,449
New +$1.6M 1.11% 25

Other funds holding LH

Ulland Investment Advisors's LH Position: Q2 2026 in Review

Ulland Investment Advisors held its Labcorp (LH) position steady in Q2 2026 at 1,043 shares worth $292K. The position accounts for 0.22% of the portfolio, ranked #67.

Ulland Investment Advisors first reported a position in LH in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.74M in Q4 2021. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Ulland Investment Advisors held 1,043 shares of Labcorp worth $292K as of Q2 2026.
  • Ulland Investment Advisors left its Labcorp share count unchanged in Q2 2026.
  • Labcorp made up 0.22% of Ulland Investment Advisors's portfolio in Q2 2026, its #67 holding.
  • Ulland Investment Advisors first reported a position in Labcorp in Q4 2021 and has held it in 19 quarters since.
  • Ulland Investment Advisors's Labcorp position peaked at $1.74M in Q4 2021.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Ulland Investment Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.